At the news
? NEUTRALIMPACT 4/10 CLUSTER filed Aug 27, 2026 at 16:05 ET
A cluster of insider selling at Twist Bioscience, led by CEO Emily Leproust selling ~$6.3M in open-market transactions on August 25, 2026, alongside the CAO, COO, CFO, and other executives selling a combined $3.27M over the prior week. The CEO's sales are large in absolute terms but represent a small fraction of the $10.2B market cap (~0.06%), and the cluster is likely driven by a shared blackout-window opening or 10b5-1 plan rather than a coordinated bearish signal.
- CEO Emily Leproust sold 41,570 shares for ~$6.3M on August 25, 2026, at prices between $150.56 and $154.45.
- Total cluster value is $3.27M across 6 insiders (CEO, CAO, COO, CFO, SVP HR, and another executive).
- The cluster represents ~0.03% of Twist's $10.2B market cap, well below the 0.1% threshold for materiality.
- No recent earnings, offering, restructuring, or late-filing cross-filings were found to amplify the signal.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access